Preliminary scientific studies suggest conolidine might inhibit specific ion channels, minimizing neuronal excitability and limiting agony signals. This system is particularly applicable in neuropathic suffering, wherever irregular signaling causes persistent pain. In addition, conolidine seems to influence G protein-coupled receptor (GPCR) pathway